Literature DB >> 30250907

Does the BCL-2 family member BIK control lung carcinogenesis?

Yohannes A Mebratu1, Yohannes Tesfaigzi1.   

Abstract

Hyperplastic airway epithelial cells may be the cause for increased risk for lung cancer in patients with chronic lung diseases. The B-cell lymphoma 2 (Bcl-2) family member, Bcl-2-interacting killer (BIK), triggers cell death specifically in these hyperplastic cells because of adequate presence of Death-associated Protein Kinase 1 (DAPk1), BCL-2 Antagonist Killer (BAK), and Extracellular Signal-regulated Kinase 1/2 (ERK1/2). Therefore, BIK may be a useful tool to control the development of lung cancer in patients with chronic diseases.

Entities:  

Year:  2018        PMID： 30250907      PMCID： PMC6150014          DOI： 10.1080/23723556.2018.1435182

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN： 2372-3556


  10 in total

1.  Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.

Authors:  Jingyung Hur; Daphne W Bell; Kathleen L Dean; Kathryn R Coser; Pablo C Hilario; Ross A Okimoto; Erica M Tobey; Shannon L Smith; Kurt J Isselbacher; Toshi Shioda
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

2.  Cigarette smoke suppresses Bik to cause epithelial cell hyperplasia and mucous cell metaplasia.

Authors:  Yohannes A Mebratu; Kurt Schwalm; Kevin R Smith; Mark Schuyler; Yohannes Tesfaigzi
Journal:  Am J Respir Crit Care Med       Date:  2011-02-11       Impact factor: 21.405

3.  Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin.

Authors:  Hassan Lemjabbar; Daizong Li; Marianne Gallup; Sukhvinder Sidhu; Ehud Drori; Carol Basbaum
Journal:  J Biol Chem       Date:  2003-04-23       Impact factor: 5.157

4.  Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.

Authors:  J M Boyd; G J Gallo; B Elangovan; A B Houghton; S Malstrom; B J Avery; R G Ebb; T Subramanian; T Chittenden; R J Lutz
Journal:  Oncogene       Date:  1995-11-02       Impact factor: 9.867

5.  Enhancement of Bik antitumor effect by Bik mutants.

Authors:  Yan M Li; Yong Wen; Binhua P Zhou; Hsu-Ping Kuo; Qingqing Ding; Mien-Chie Hung
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

6.  Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death.

Authors:  Leigh Coultas; Philippe Bouillet; Edouard G Stanley; Thomas C Brodnicki; Jerry M Adams; Andreas Strasser
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals.

Authors:  Yi-Ping Rong; Ademuyiwa S Aromolaran; Geert Bultynck; Fei Zhong; Xiang Li; Karen McColl; Shigemi Matsuyama; Stephan Herlitze; H Llewelyn Roderick; Martin D Bootman; Gregory A Mignery; Jan B Parys; Humbert De Smedt; Clark W Distelhorst
Journal:  Mol Cell       Date:  2008-07-25       Impact factor: 17.970

8.  Resolution of LPS-induced airway inflammation and goblet cell hyperplasia is independent of IL-18.

Authors:  J Foster Harris; Jay Aden; C Rick Lyons; Yohannes Tesfaigzi
Journal:  Respir Res       Date:  2007-03-12

9.  The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death.

Authors:  Yohannes A Mebratu; Burton F Dickey; Chris Evans; Yohannes Tesfaigzi
Journal:  J Cell Biol       Date:  2008-11-03       Impact factor: 10.539

10.  Bik reduces hyperplastic cells by increasing Bak and activating DAPk1 to juxtapose ER and mitochondria.

Authors:  Yohannes A Mebratu; Ivan Leyva-Baca; Marc G Wathelet; Neal Lacey; Hitendra S Chand; Augustine M K Choi; Yohannes Tesfaigzi
Journal:  Nat Commun       Date:  2017-10-06       Impact factor: 14.919
  10 in total
  3 in total

Review 1.  Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation.

Authors:  Vladimir Jurišić; Jasmina Obradovic; Sonja Pavlović; Nataša Djordjevic
Journal:  Anal Cell Pathol (Amst)       Date:  2018-10-14       Impact factor: 2.916

2.  Gene Amplification-Driven Long Noncoding RNA SNHG17 Regulates Cell Proliferation and Migration in Human Non-Small-Cell Lung Cancer.

Authors:  Tianwei Xu; Shuai Yan; Lihua Jiang; Shanxun Yu; Tianyao Lei; Daolu Yang; Binbin Lu; Chenchen Wei; Erbao Zhang; Zhaoxia Wang
Journal:  Mol Ther Nucleic Acids       Date:  2019-06-20

3.  Copy number amplification-activated long non-coding RNA LINC00662 epigenetically inhibits BIK by interacting with EZH2 to regulate tumorigenesis in non-small cell lung cancer.

Authors:  Chunluan Yuan; Yue Ding; Yan Zhuang; Chongguo Zhang; Liang Han; Wei Li; Renhua Guo; Erbao Zhang
Journal:  J Cancer       Date:  2022-03-14       Impact factor: 4.207
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.